Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134625) titled 'Clinical research on the consolidation treatment of berintoumab after allogeneic hematopoietic stem cell transplantation of refractory recurrent acute B lymphocytic leukemia in children' on Oct. 17.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking University People's Hospital
Condition:
Acute B-cell lymphoblastic leukemia
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-24
Target Sample Size: Intervention group:41;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=267941
Disclaimer: Curated b...